Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence. (Q54404821)

29 May 2018

title

Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence. (English)

1 reference

29 May 2018

main subject

toll-like receptor

0 references

author name string

Salomé González-Reyes

1

1 reference

29 May 2018

Jesús M Fernández

2

1 reference

29 May 2018

Luis O González

3

1 reference

29 May 2018

Alina Aguirre

4

1 reference

29 May 2018

Aurelio Suárez

5

1 reference

29 May 2018

José M González

6

1 reference

29 May 2018

Safwan Escaff

7

1 reference

29 May 2018

Francisco J Vizoso

8

1 reference

29 May 2018

publication date

27 October 2010

1 reference

29 May 2018

Cancer Immunology, Immunotherapy

published in

1 reference

29 May 2018

volume

60

1 reference

29 May 2018

issue

2

1 reference

29 May 2018

page(s)

217-226

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/s00262-010-0931-0

exact match

0 references

cites work

Prostate cancer epidemiology

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Dendritic cells and cytokines in immune rejection of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Developmental phases of inflammation-induced massive lymphoid hyperplasia and extensive changes in epithelium in an experimental model of allergy: implications for a direct link between inflammation and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Cancer surveillance in inflammatory bowel disease: new molecular approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Lymphocyte-mediated immunosurveillance of epithelial cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Cancer; a biological approach. I. The processes of control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

HPV: from infection to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

TLR3 can directly trigger apoptosis in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Toll-like receptors and their role in carcinogenesis and anti-tumor treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Toll-like receptor signaling pathway variants and prostate cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

The interface between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Paradoxical roles of the immune system during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Study of matrix metalloproteinases and their inhibitors in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

IL-18 is produced by prostate cancer cells and secreted in response to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Cytokine genetic polymorphisms and prostate cancer aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Microbial DNA induces a host defense reaction of human respiratory epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Human lung cancer cells express functionally active Toll-like receptor 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Recognition of pathogen-associated molecular patterns by TLR family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Chronic bacterial prostatitis: an evolving clinical enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

The role of inflammation in the pathogenesis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

Inflammation and prostate cancer: a future target for prevention and therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

An approach for understanding the inflammation and cancer relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0931-0

10.1007/S00262-010-0931-0

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

20978888

1 reference

29 May 2018